Amir Nashat, Director at FATE THERAPEUTICS INC (FATE), sold 208,775 shares at $22.50 ($4.7M) on 2019-07-26, disclosed to the SEC on 2019-07-30.
Open-market sale of $4.7M FATE by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $22.50 | 184 | $4K | 0.1% |
| 2 | $22.50 | 270 | $6K | 0.1% |
| 3 | $22.50 | 523 | $12K | 0.3% |
| 4 | $22.50 | 26,852 | $604K | 12.9% |
| 5 | $22.50 | 270 | $6K | 0.1% |
| 6 | $22.50 | 317 |
| $7K |
| 0.2% |
| 7 | $22.50 | 3 | $68 | 0.0% |
| 8 | $22.50 | 6 | $135 | 0.0% |
| 9 | $22.51 | 596 | $13K | 0.3% |
| 10 | $22.51 | 873 | $20K | 0.4% |
| 11 | $22.51 | 1,696 | $38K | 0.8% |
| 12 | $22.51 | 87,010 | $2.0M | 41.7% |
| 13 | $22.51 | 87,010 | $2.0M | 41.7% |
| 14 | $22.51 | 596 | $13K | 0.3% |
| 15 | $22.51 | 1,696 | $38K | 0.8% |
| 16 | $22.51 | 873 | $20K | 0.4% |
| Total | $22.51 avg | 208,775 | $4.7M | 100% |
| Filing → |
| SRRK | BUY | 2022-06-24 | $6.2M | — | Filing → |
| MORF | SELL | 2021-05-25 | $20.4M | — | Filing → |
| MTCR | BUY | 2020-09-22 | $3.0M | — | Filing → |